Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    October 2022
  1. HSIAO V, Hanlon BM, Robbins SE, Connor NP, et al
    Discovering domains important to health-related quality of life in differentiated thyroid cancer.
    Am J Surg. 2022;224:1176-1178.
    PubMed    


    September 2022
  2. FUNG MMH, Lang BH
    A prospective study evaluating the use of low-dose intravenous sedation and analgesia during radiofrequency ablation of symptomatic, benign thyroid nodules.
    Am J Surg. 2022;224:928-931.
    PubMed     Abstract available


    August 2022
  3. HARVEY A
    Using what we already have: Optimizing information from ultrasound and fine needle aspiration biopsy for decision making in thyroid nodular disease.
    Am J Surg. 2022;224:652.
    PubMed    


  4. PAJAK C, Cadili L, Nabata K, Wiseman SM, et al
    (68)Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: A systematic review.
    Am J Surg. 2022;224:670-675.
    PubMed     Abstract available


  5. DICKEY MV, Nguyen A, Wiseman SM
    Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.
    Am J Surg. 2022;224:653-656.
    PubMed     Abstract available


  6. SUJKA J, DuCoin CG
    Dr. Velanovich's contributions to understanding Barrett's Esophagus and its treatment.
    Am J Surg. 2022;224:821-822.
    PubMed    


    July 2022
  7. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    PubMed     Abstract available


  8. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    PubMed     Abstract available


    April 2022
  9. TAKEDA E, Kimura J, Okabayashi T, Sui K, et al
    Clinicopathological features and surgical outcomes of pancreatic metastasis from thyroid cancer.
    Am J Surg. 2022 Apr 12. pii: S0002-9610(22)00237.
    PubMed     Abstract available


  10. ZMIJEWSKI P, Kuo LE
    Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?
    Am J Surg. 2022;223:633-634.
    PubMed    


  11. RAMONELL KM, Yip L
    The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management.
    Am J Surg. 2022;223:615-616.
    PubMed    


  12. ZHENG H, Lai V, Lu J, Kang JK, et al
    Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity.
    Am J Surg. 2022;223:617-623.
    PubMed     Abstract available


  13. RAMONELL KM, Rentas C, Buczek E, Porterfield J Jr, et al
    Mediastinal parathyroidectomy: Utilization of a multidisciplinary, robotic-assisted transthoracic approach in challenging cases.
    Am J Surg. 2022;223:681-685.
    PubMed     Abstract available


  14. MATSON J, Lwin TM, Bouvet M
    Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
    Am J Surg. 2022;223:686-693.
    PubMed     Abstract available


    February 2022
  15. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00091.
    PubMed    


  16. SHALABY M, Hadedeya D, Toraih EA, Razavi MA, et al
    Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
    Am J Surg. 2022;223:287-296.
    PubMed     Abstract available


    January 2022
  17. KELLEY S, Beck AC, Weigel RJ, Howe JR, et al
    Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.
    Am J Surg. 2022;223:76-80.
    PubMed     Abstract available


    December 2021
  18. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2021 Dec 9. pii: S0002-9610(21)00724.
    PubMed     Abstract available


    October 2021
  19. ARYANPOUR Z, Asban A, Boyd C, Herring B, et al
    A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers?
    Am J Surg. 2021;222:802-805.
    PubMed     Abstract available


    September 2021
  20. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.
    PubMed    


  21. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    PubMed     Abstract available


  22. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    PubMed     Abstract available


    August 2021
  23. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    PubMed     Abstract available


  24. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    PubMed     Abstract available


    July 2021
  25. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    PubMed     Abstract available


  26. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    PubMed     Abstract available


    June 2021
  27. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.
    PubMed    


  28. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    PubMed     Abstract available


    May 2021
  29. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    PubMed     Abstract available


  30. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    PubMed     Abstract available


    April 2021
  31. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    PubMed     Abstract available


    March 2021
  32. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    PubMed     Abstract available


  33. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: